Sanofi reprimanded for disparaging Pfizer’s RSV vaccine
A U.K. marketing watchdog has reprimanded Sanofi for using “a highly misleading interpretation of data” to make disparaging…
Sanofi opens new chapters in Pfizer, Moderna mRNA patent litigation sagas
As Pfizer and Moderna have tied off certain threads in their separate webs of mRNA patent litigation, Sanofi…
Novavax bets on ‘amplification strategy’ with Sanofi, Pfizer deals
Beginning in 2023, Novavax embarked on an identity shift, moving away from the fully integrated business ambitions once…